Developers Taconic Investment Partners and Silverstein Properties are spending $20 million to renovate the 326,861-sf Movie Lab building in Midtown Manhattan for life science research usage.

The New York Post reports that the Stem Cell Foundation has leased 42,100 sf in this building since 2015. Another 150,000 sf on the top floors of this 10-story building are being upgraded to attract more life science tenants. The building reportedly is changing its name to the Hudson Research Center.

Image: https://www.bdcnetwork.com

The federal government's latest innovation initiative – in which $950-million is up for grabs for three to five superclusters – contains a mix of new and old thinking. The focus on sectors is new. So is the fact that these entities are to be industry-led. Unfortunately, an old paradigm is still driving it.

For decades, politicians and pundits have been decrying the relatively poor standing Canada holds among OECD countries in rankings of R&D spending as a percentage of GDP (GERD/GDP). While our higher education spending on R&D (HERD) is among the highest, our business expenditure on R&D (BERD) is among the lowest.

The top 10% of earners made at least $170,500, last year — nearly three times the amount the typical American household earned.

The new figures come from the Census Bureau's annual study of incomes, poverty and health insurance in the U.S.

Within the report, there were several nuggets to be optimistic about. After stalling out following the housing crisis, middle-class incomes are growing again at a healthy rate. The median income in the U.S. is now $59,000, which rose by more than $1,800 from $57,200 in 2015.

Young Europeans do not need short-term, tokenistic initiatives but long-lasting and sustainable solutions that make a real impact, and these need to be developed with our input. We are the most pro-European generation and have the potential to be the driving force of its future, writes Anna Widegren.

Before an angel investor or venture capital firm will invest in a startup, the business has to prove its viability through a lengthy review process called due diligence. Startups often prepare tens to hundreds of pages of documentation and give presentations to investors, advisors and lawyers on every aspect of their business, from the broad vision and strategy all the way to specific financial projections, in-depth market analysis and more.

If you ask 100 people why they are an entrepreneur, you will get a wide range of responses.

For some, it offers freedom of their time or the creation of financial abundance. For others, it is the chance to create a product or service that impacts lives. Yet others desire the ability to grow and innovate ultimately changing an industry.

The federal government's latest innovation initiative – in which $950-million is up for grabs for three to five superclusters – contains a mix of new and old thinking. The focus on sectors is new. So is the fact that these entities are to be industry-led. Unfortunately, an old paradigm is still driving it.

For decades, politicians and pundits have been decrying the relatively poor standing Canada holds among OECD countries in rankings of R&D spending as a percentage of GDP (GERD/GDP). While our higher education spending on R&D (HERD) is among the highest, our business expenditure on R&D (BERD) is among the lowest. So, the policy mantra is "Canadian business should spend more on R&D." Hundreds of programs exist to get Canadian companies to up their R&D game – and if the superclusters initiative goes down the same path, we're in big trouble.

WILL your university degree get you a job?

As universities come under fire for being out of touch and training people for jobs that won’t exist, The Courier-Mail presents an exclusive three-part report on graduate employability.

Which institutions are best preparing students for the changing world of work?

Crunching the latest global data (*see our sources at the end of this article) and drilling down into individual strengths, we reveal the top 21 Queensland and eastern seaboard universities kicking goals for grads.

American Express sent me an email recently which immediately got my attention. The subject line read: Fraud Protection Alert. The email included a date, a place–Saks; an amount–710 USD; and finally, the notice: Not Approved.

Yes, they were right, this was a case of fraud.

I’m always amazed at how good American Express is at knowing what I might buy and what I certainly wouldn’t. Since I travel randomly around the world, often to out-of-the-way places where I buy odd things, this feat is particularly amazing.

If dreams were movies, they wouldn't make a dime. They're often banal, frequently fleeting and they're screened for an audience of just one. As for the storyline? You're in a supermarket, only it's also Yankee Stadium, shopping with your second-grade teacher until she turns into Ruth Bader Ginsburg. Then you both shoot a bear in the cereal aisle. Somebody call rewrite.

But dreams are vastly more complex than that, and if you've got a theory that explains them, have at it. The ancient Egyptians thought of dreams as simply a different form of seeing, with trained dreamers serving as seers to help plan battles and make state decisions. The ancient Greeks and Romans believed that dreams were equal parts predictions of future events and visitations by the dead.

Image: http://time.com - From Video

In 1991, ten-year-old Jerry Nemorin and his family escaped civil war in Haiti and resettled in Florida. Jerry’s first experience with the US financial system was when his mom tried to buy a car.

Twenty-five years later, Jerry still remembers the sign above the auto lot: “BUY HERE, PAY HERE.” Jerry’s mom was an immigrant and didn’t have any credit, so she took out a loan directly from the shop. “I was only twelve,” remembers Jerry, “but looking through the loan documents, I saw that the interest on the loan would cost more than the car itself.” But Jerry’s mom didn’t have a choice.

Image: Jerry Nemorin is founder of LendStreet JPMorgan

The innovation economy needs a new kind of employee, and that means higher education institutions need to better prepare graduates for this new world. Fast-paced technology upgrades and globalization have forever changed the workplace, and that means that most traditional paths of study are no longer enough by themselves to prepare graduates for the constant need to adapt.

Image: Gloria Cordes Larson is the President of Bentley University and author of PreparedU: How Innovative Colleges Drive Student Success

Baton Rouge, La. — Three months after Hurricane Katrina ravaged my home state of Louisiana in 2005, my wife and I took our family to Florida for a few days to get away from it all. The storm had spared our home, but the recovery added big burdens to our professional lives, and the work exhausted us. A week in Orlando with our two small children proved good medicine.

Our visit reminded me of other times when Florida renewed my spirit. When I lost my father as a teenager, going to Pensacola eased my grief. I brought back a few seashells as souvenirs, and the sound they made when cupped to my ear seemed like the voice of nature itself, intimate and inexhaustible.

Image: Waves crashing against a seawall in Jensen Beach, Fla., on Saturday. Credit Jason Henry for The New York Times

Machine learning, AI, predictive analytics, and other flourishing technologies are remaking the business landscape today. A brave new world is upon us, where every industry from agriculture to healthcare and commerce to advertising is innovating exponentially. The leaders and visionaries ushering in this exciting new era are the entrepreneurs behind the brilliant platforms being developed. Below are 20 innovative technology companies transforming their industries and moving the needle forward for all of us.

The iPhone, arguably Apple’s most revolutionary product, turned 10 years old earlier this year and the next version, the iPhone 8, is set to be introduced Sept. 12. In honor of these momentous events, The Daily Caller News Foundation took a look at every iPhone ever created in chronological order — from the relative “duds” to the “must have’s.”

Humanity has arrived at a critical threshold in the evolution of computing. By 2020, an estimated 50 billion devices around the globe will be connected to the Internet. Perhaps a third of them will be computers, smartphones, tablets, and TVs. The remaining two-thirds will be other kinds of “things”: sensors, actuators, and newly invented intelligent devices that monitor, control, analyze, and optimize our world.

Everyone talks about innovation. Many governments, universities, and corporations spend fortunes to innovate – to develop new businesses that can create wealth and jobs. But the real money in new products and emerging industries has been made by billion-dollar entrepreneurs, such as Gates, Jobs, Dell, Page-Brin, and Zuckerberg. They have become among the world’s richest individuals by using innovations.

What does it really cost to bring a drug to market?

The question is central to the debate over rising health care costs and appropriate drug pricing. President Trump campaigned on promises to lower the costs of drugs.

But numbers have been hard to come by. For years, the standard figure has been supplied by researchers at the Tufts Center for the Study of Drug Development: $2.7 billion each, in 2017 dollars.

Most of us in the entrepreneurial community are blessed -- or cursed -- with higher-than-average ambition. Ambitious people crave accomplishments, whether that means becoming more recognized and powerful or making more money, and are usually willing to take more risks and spend more effort to get them.

Overall, this is a positive quality, especially for people trying to build their own businesses. Obviously, if you're more naturally driven to set goals and accomplish them, you'll be more likely to succeed than someone who isn't, right?

Every year, as part of their strategic planning, executives’ minds turn to setting performance targets—and then achieving them. In so doing, those at medical-device companies should bear in mind the high hopes shareholders have for future growth. Can these hopes be met?

The global medical-device sector has performed well in recent years, recording average total returns to shareholders (TRS) of 18 percent a year from 2011 to 2016, compared with 15 percent for the S&P 500. A subset of the largest medical-device companies also outperformed the S&P 500 over this time frame, averaging 15.5 percent TRS (Exhibit 1).

Image: http://www.mckinsey.com